Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ABVX.PAthis companyAbivax S.A.	€77.70	-24.93×	18.39×	0×	-31.6×	-91.3%	0.0%	0.0%	0.0%	-73.8%	-48.0%	-1.9%	0.07×	1.94×	-8.79×	8.75×	0.0%	3	37.94	2	C
AB.PAAB Science S.A.	€0.51	-60.63×	-5.48×	80.33×	-72.6×	-113.1%	61.3%	-103.7%	-132.6%	9.1%	-5.5%	-4.8%	-0.25×	4.88×	-0.86×	0.96×	0.0%	4	-1.17	2	C
ALCLS.PACellectis S.A.	€1.05	-7.05×	6.52×	6.52×	-24.8×	-443.6%	72.5%	-55.3%	-92.7%	-92.7%	-19.9%	-8.9%	1.2×	-1.38×	-4.98×	1.62×	0.0%	2	-1.71	1	D+
ALVIO.PAValerio Therapeutics S.A.	€0.49	-4.35×	10.27×	8.28×	51.4×	-135.2%	67.1%	-21.4%	-190.4%	-236.0%	-5.5%	2.4%	3.67×	12.09×	-1.96×	0.76×	0.0%	6	5.8	2	C
IPH.PAInnate Pharma S.A.	€1.31	-2.91×	-6.59×	51.33×	-2.46×	-112.1%	100.0%	-2058.0%	-1764.5%	226.6%	-146.1%	-37.0%	-1.04×	0.1×	-18.38×	1.27×	0.0%	3	-22.95	2	C
MAAT.PAMaaT Pharma S.A.	€1.09	-2.47×	42.6×	16.94×	-2.14×	-1697.1%	30.7%	-754.9%	-686.6%	-1726.6%	-101.2%	-21.6%	9.69×	0.23×	-26.91×	1.94×	0.0%	2	-3.83	2	C
Peer median	—	-4.35×	6.52×	16.94×	-2.46×	-135.2%	67.1%	-103.7%	-190.4%	-92.7%	-19.9%	-8.9%	1.2×	0.23×	-4.98×	1.27×	0.0%	3	-1.71	2	—